SCHEMBL7084675

SCHEMBL7084675

Cc1nc(C)c(-c2ccnc(Nc3ccc(O)c([N+](=O)[O-])c3)n2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 12/20 0.52
CDK4 P11802 10/20 0.52
ABCG2 Q9UNQ0 2/20 0.44
ABCC1 P33527 1/20 0.44
IKBKB O14920 1/20 0.44
ABL1 P00519 3/20 0.43
CCNT1 O60563 2/20 0.43
CDK1 P06493 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNA2 P20248 2/20 0.43
CDK7 P50613 2/20 0.43
CDK9 P50750 2/20 0.43
CCNH P51946 2/20 0.43
AURKA O14965 1/20 0.43
CCNB2 O95067 1/20 0.43
CCNE2 O96020 1/20 0.43
CCND1 P24385 1/20 0.43
CCNE1 P24864 1/20 0.43
ABL2 P42684 1/20 0.43
GSK3B P49841 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158465 0.82 CDK2 (0.75) CDK2CDK4ABL1CCNT1CDK1
SCHEMBL6157065 0.78 CDK2 (0.70) CDK2CDK4ABL1CCNT1CDK1
SCHEMBL14254276 0.78 PIK3CA (0.51) CDK2CDK4ABCG2ABCC1IKBKB
SCHEMBL7084672 0.78 CDK2 (0.47) CDK2CDK4ABCG2ABCC1IKBKB
SCHEMBL14254270 0.75 SRC (0.50) CDK2CDK4IKBKBABL1PLK1
SCHEMBL14254260 0.74 DKK1 (0.59) ABCG2ABCC1IKBKBABL1GSK3B
SCHEMBL14254274 0.73 ABCG2 (0.54) CDK2CDK4ABCG2IKBKBABL1
SCHEMBL14254254 0.73 PIK3CA (0.68) CDK2CDK4ABCG2IKBKBABL1
SCHEMBL14253963 0.73 PLK1 (0.57) IKBKBABL1GSK3BPLK1BCR
SCHEMBL14254214 0.72 ABL1 (0.55) CDK2CDK4IKBKBABL1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1274705-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2003-01-15 EP disclosed
WO-2001072745-A1 2-SUBSTITUTED 4-HETEROARYL-PYRIMIDINES AND THEIR USE IN THE TREATMETN OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2001-10-04 WO disclosed